Clinical Trial Update: Imaging of Residual Tumor During Prostatectomy

View source ↗

Summary

The clinical trial 'Imaging of Residual Tumor During Prostatectomy' (NCT01173146) sponsored by Spectros Corporation has been withdrawn and is no longer active.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Spectros Corporation | Conditions: Prostate Cancer | Status: WITHDRAWN